ҽѧÂÛÎÄ·¶ÎÄ:¼ä³äÖʸÉϸ°ûÓÃÓÚÀà·çʪ¹Ø½ÚÑ×ÖÎÁƵÄÀíÂÛ¼°Ó¦ÓÃÇ°¾°

¡¾²Î¿¼ÎÄÏס¿
  ¡¡ [1] Dorner T, Burmester GR. The role of B cells in rheumatoid arthritis: mechanisms and therapeutic targels[J]. Curr Opin Rheumatol, 2003, 15(3): 246-251.

[2] Kim WU, Kim KJ. T cell proliferate response to type II collagen in the inflammatory process and joint damage in patients with rheumatoid arthritis[J]. J Rheumatol, 2005, 32(3): 225-230.

[3] Lubberts E, Schwarzenberger P, Huang W, et al. Requirement of ILª²17 receptor signaling in radiationresistant cells in the joint for full progression of destructive synovitis[J]. J Immunol, 2005, 175(5): 3360-3368.

[4] Giles JT, Bartlett SJ, Gelber AC, et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in Rheumatoid Arthritis[J]. Arthritis Care Res, 2006, 55(4): 333-337.

[5] Kastrinaki MC, Papadaki HA. Mesenchymal stromal cells in rheumatoid arthritis: biological properties and clinical applications[J]. Curr Stem Cell Res Ther, 2009, 4(1): 61-69.

[6] Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs[J]. Exp Hematol, 1976, 4: 267-274Ò½.ѧȫ.ÔÚ.ÏßÍøÕ¾www.lindalemus.com.

[7] Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8(4): 315-317.

[8] Kalwitz G, Endres M, Neumann K, et al. Gene expression profile of adult human bone marrowª²derived mesenchymal stem cells stimulated by the chemokine CXCL7[J]. Int J Biochem Cell Biol, 2009, 41(3): 649-658.

[9] Gao J, Dennis JE, Solchaga LA, et al. Tissue engineered fabrication of an osteochondral composite graft using rat bone marrow derived mesenchymal stem cells[J]. Tissue Eng, 2001, 7(4): 363-371.

[10] Frangogiannis NG. The immune system and cardiac repair[J]. Pharmacol Res, 2008, 58(2): 88-111.

[11] Kassis I, Grigoriadis N, Gowdaª²Kurkalli B, et al. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis[J]. Arch Neurol, 2008, 65(6): 753-761.

[12] Okada H, Suzuki J, Futamatsu H, et al. Attenuation of autoimmune myocarditis in rats by mesenchymal stem cell transplantation through enhanced expression of hepatocyte growth factor[J]. Int Heart J, 2007, 48(5): 649-661.

[13] Blanc KL, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroidª²resistant, severe, acute graftª²versusª²host disease: a phase II studies[J]. Lancet, 2008, 371(9624): 1579-1586.

[14] Guangwen Ren, Liying Zhang, Xin Zhao, et al. Mesenchymal stem cell mediated immunosuppres occurs via concerted action of chemokines and nitric oxide[J].Cell Stem Cell, 2008, 2: 141-150.

[15] MarinovaM L, Williams RO, Funa K, et al. Inflammation is preceded by tumor necrosis factorª²dependent infiltration of mesenchymal cells in experimental arthritis[J]. Arthritis Rheum, 2002, 46: 507-513.

[16] Djouad F, Fritz V, Apparailly F, et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagenª²induced arthritis[J]. Arthritis Rheum, 2005, 52: 1595-1603.

[17] Andrea Augello. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevent tissue damage in collagenª²induced arthritis[J]. Arthritis Rheum, 2007, 56(4): 1175.

[18] Zheng ZH, Li XY, Ding J, et al. Allogeneic mesenchymal stem cell and mesenchymal stem cellª²differentiated chondrocyte suppress the responses of type II collagenª²reactive T cells in rheumatoid arthritis[J]. Rheumatology (Oxford), 2008, 47(1): 22-30.

ÉÏÒ»Ò³  [1] [2] [3] [4]  ÏÂÒ»Ò³